# Yelp timeline

entity: /record/yelp.md  
id: ent_yelp  


## undated

- undated | listed_on | NYSE | valid | [clm_15D98530AA76](/claim/clm_15D98530AA76.md)
- undated | state_of_incorporation | DE | valid | [clm_2398F321FD1B](/claim/clm_2398F321FD1B.md)
- undated | fiscal_year_end | 12-31 | valid | [clm_425CA73735C2](/claim/clm_425CA73735C2.md)
- undated | sic_industry | Services-Personal Services (7200) | valid | [clm_971E6AAC9BFD](/claim/clm_971E6AAC9BFD.md)
- undated | cik | 0001345016 | valid | [clm_A75CE60732A2](/claim/clm_A75CE60732A2.md)
- undated | ticker | YELP | valid | [clm_B14604B3FDE8](/claim/clm_B14604B3FDE8.md)
- undated | member_of | Internet Association | unverified | [clm_14136D25ADB6](/claim/clm_14136D25ADB6.md)

## 2004

- 2004-01-01 | ceo | Jeremy Stoppelman | valid | [clm_2DC99A67BC56](/claim/clm_2DC99A67BC56.md)
- 2004-01-01 | founded | 2004-01-01 | unverified | [clm_356D1A8102C7](/claim/clm_356D1A8102C7.md)

## undated

- undated | country | United States | unverified | [clm_35CDB72AE620](/claim/clm_35CDB72AE620.md)
- undated | website | https://www.yelp.com/ | unverified | [clm_539813051BA7](/claim/clm_539813051BA7.md)
- undated | headquarters | 140 New Montgomery | valid | [clm_82D6F89CDA59](/claim/clm_82D6F89CDA59.md)
- undated | website | https://www.yelp.co.uk | unverified | [clm_E6BA8F0978FB](/claim/clm_E6BA8F0978FB.md)
- undated | legal_form | joint-stock company | unverified | [clm_FD68C27B3564](/claim/clm_FD68C27B3564.md)

## 2005

- 2005-11-16 | registrant_name | YELP INC | valid | [clm_DC3B30569A32](/claim/clm_DC3B30569A32.md)

## 2008

- 2008-11-06 | x_username | Yelp | unverified | [clm_45764B46521D](/claim/clm_45764B46521D.md)

## 2009

- 2009-12-31 to 2010-12-31 | total_equity | -13,169,000 United States dollar | superseded | [clm_68B2EBEAA5C2](/claim/clm_68B2EBEAA5C2.md)
- 2009-12-31 to 2010-12-31 | cash_and_equivalents | 15,074,000 United States dollar | superseded | [clm_90483D270568](/claim/clm_90483D270568.md)

## 2010

- 2010-12-31 to 2011-12-31 | research_and_development | 6,560,000 United States dollar | superseded | [clm_4912AC65B9E4](/claim/clm_4912AC65B9E4.md)
- 2010-12-31 to 2011-12-31 | net_income | -9,566,000 United States dollar | superseded | [clm_4918BD7CAA3C](/claim/clm_4918BD7CAA3C.md)
- 2010-12-31 to 2011-03-31 | cash_and_equivalents | 27,074,000 United States dollar | superseded | [clm_50F8DE863ADC](/claim/clm_50F8DE863ADC.md)
- 2010-12-31 to 2011-12-31 | revenue | 47,731,000 United States dollar | superseded | [clm_A34094F0ADC0](/claim/clm_A34094F0ADC0.md)
- 2010-12-31 to 2011-12-31 | total_equity | -20,889,000 United States dollar | superseded | [clm_E521F76A0F9E](/claim/clm_E521F76A0F9E.md)
- 2010-12-31 to 2011-12-31 | operating_income | -9,506,000 United States dollar | superseded | [clm_FA24FD26AE0D](/claim/clm_FA24FD26AE0D.md)

## 2011

- 2011-03-31 to 2011-06-30 | quarterly_net_income | -2,706,000 United States dollar | superseded | [clm_287BBE965835](/claim/clm_287BBE965835.md)
- 2011-03-31 to 2011-06-30 | quarterly_revenue | 16,500,000 United States dollar | superseded | [clm_5C4F856AA3AC](/claim/clm_5C4F856AA3AC.md)
- 2011-03-31 to 2011-06-30 | quarterly_research_and_development | 2,319,000 United States dollar | superseded | [clm_C38443F9B0F9](/claim/clm_C38443F9B0F9.md)
- 2011-03-31 to 2011-06-30 | cash_and_equivalents | 26,765,000 United States dollar | superseded | [clm_C45807D66E04](/claim/clm_C45807D66E04.md)
- 2011-03-31 to 2011-06-30 | quarterly_operating_income | -2,802,000 United States dollar | superseded | [clm_F370B3BF411A](/claim/clm_F370B3BF411A.md)
- 2011-06-30 to 2011-09-30 | quarterly_revenue | 19,578,000 United States dollar | superseded | [clm_011BE2009F99](/claim/clm_011BE2009F99.md)
- 2011-06-30 to 2011-09-30 | cash_and_equivalents | 25,143,000 United States dollar | superseded | [clm_27AE6BE00B28](/claim/clm_27AE6BE00B28.md)
- 2011-06-30 to 2011-09-30 | quarterly_net_income | -1,165,000 United States dollar | superseded | [clm_4CA09C2ADC85](/claim/clm_4CA09C2ADC85.md)
- 2011-06-30 to 2011-09-30 | quarterly_research_and_development | 2,661,000 United States dollar | superseded | [clm_88A3BCCC07D8](/claim/clm_88A3BCCC07D8.md)
- 2011-06-30 to 2011-09-30 | quarterly_operating_income | -1,223,000 United States dollar | superseded | [clm_D11EEF56B338](/claim/clm_D11EEF56B338.md)
- 2011-09-30 to 2012-03-31 | quarterly_research_and_development | 3,444,000 United States dollar | superseded | [clm_794C77961D76](/claim/clm_794C77961D76.md)
- 2011-09-30 to 2012-03-31 | quarterly_operating_income | -3,389,000 United States dollar | superseded | [clm_AF1D154863EF](/claim/clm_AF1D154863EF.md)
- 2011-09-30 to 2011-12-31 | cash_and_equivalents | 23,128,000 United States dollar | superseded | [clm_BA9F4FB91BB2](/claim/clm_BA9F4FB91BB2.md)
- 2011-09-30 to 2012-03-31 | quarterly_net_income | -3,751,000 United States dollar | superseded | [clm_C2C5225FAE31](/claim/clm_C2C5225FAE31.md)
- 2011-09-30 to 2012-03-31 | quarterly_revenue | 22,302,000 United States dollar | superseded | [clm_CAAA81BAC5C7](/claim/clm_CAAA81BAC5C7.md)
- 2011-12-31 to 2012-03-31 | cash_and_equivalents | 21,736,000 United States dollar | superseded | [clm_4C28A80E7015](/claim/clm_4C28A80E7015.md)
- 2011-12-31 to 2012-12-31 | operating_income | -16,171,000 United States dollar | superseded | [clm_6622778C6C55](/claim/clm_6622778C6C55.md)
- 2011-12-31 to 2012-12-31 | net_income | -16,668,000 United States dollar | superseded | [clm_892E9884A139](/claim/clm_892E9884A139.md)
- 2011-12-31 to 2012-12-31 | revenue | 83,285,000 United States dollar | superseded | [clm_9274A51C2D35](/claim/clm_9274A51C2D35.md)
- 2011-12-31 to 2012-03-31 | total_equity | -24,347,000 United States dollar | superseded | [clm_CF692EF87CFD](/claim/clm_CF692EF87CFD.md)
- 2011-12-31 to 2012-03-31 | total_assets | 43,821,000 United States dollar | superseded | [clm_DD697E7A30F2](/claim/clm_DD697E7A30F2.md)
- 2011-12-31 to 2012-12-31 | research_and_development | 11,586,000 United States dollar | superseded | [clm_E7A0D895FAD9](/claim/clm_E7A0D895FAD9.md)

## 2012

- 2012-03-02 | listed_on | New York Stock Exchange | valid | [clm_C269C8B161E5](/claim/clm_C269C8B161E5.md)
- 2012-03-31 to 2012-06-30 | quarterly_operating_income | -9,741,000 United States dollar | superseded | [clm_2EBDBF133C4E](/claim/clm_2EBDBF133C4E.md)
- 2012-03-31 to 2012-06-30 | quarterly_revenue | 27,385,000 United States dollar | superseded | [clm_441E27466A55](/claim/clm_441E27466A55.md)
- 2012-03-31 to 2012-06-30 | cash_and_equivalents | 130,737,000 United States dollar | superseded | [clm_8B9EDF85FE67](/claim/clm_8B9EDF85FE67.md)
- 2012-03-31 to 2012-06-30 | quarterly_net_income | -9,802,000 United States dollar | superseded | [clm_9271842175E0](/claim/clm_9271842175E0.md)
- 2012-03-31 to 2012-06-30 | quarterly_research_and_development | 4,140,000 United States dollar | superseded | [clm_983B08DF5A92](/claim/clm_983B08DF5A92.md)
- 2012-03-31 to 2012-06-30 | total_assets | 153,087,000 United States dollar | superseded | [clm_A23B3401987F](/claim/clm_A23B3401987F.md)
- 2012-03-31 to 2012-06-30 | total_equity | 140,614,000 United States dollar | superseded | [clm_D618030CF4FF](/claim/clm_D618030CF4FF.md)
- 2012-06-30 to 2012-09-30 | cash_and_equivalents | 122,613,000 United States dollar | superseded | [clm_0B93EE3EB1DB](/claim/clm_0B93EE3EB1DB.md)
- 2012-06-30 to 2012-09-30 | total_assets | 153,848,000 United States dollar | superseded | [clm_100E3AA741D1](/claim/clm_100E3AA741D1.md)
- 2012-06-30 to 2012-09-30 | quarterly_research_and_development | 4,336,000 United States dollar | superseded | [clm_9E79145E7F85](/claim/clm_9E79145E7F85.md)
- 2012-06-30 to 2012-09-30 | total_equity | 140,678,000 United States dollar | superseded | [clm_AD1DAE53A1AD](/claim/clm_AD1DAE53A1AD.md)
- 2012-06-30 to 2012-09-30 | quarterly_net_income | -1,982,000 United States dollar | superseded | [clm_B0AB0338FE04](/claim/clm_B0AB0338FE04.md)
- 2012-06-30 to 2012-09-30 | quarterly_operating_income | -1,938,000 United States dollar | superseded | [clm_BFBC4D3A1719](/claim/clm_BFBC4D3A1719.md)
- 2012-06-30 to 2012-09-30 | quarterly_revenue | 32,653,000 United States dollar | superseded | [clm_FDAB8D414C42](/claim/clm_FDAB8D414C42.md)
- 2012-09-30 to 2013-03-31 | quarterly_operating_income | -1,952,000 United States dollar | superseded | [clm_0EAFAFA2FE06](/claim/clm_0EAFAFA2FE06.md)
- 2012-09-30 to 2012-12-31 | total_assets | 156,532,000 United States dollar | superseded | [clm_339AFC5A3014](/claim/clm_339AFC5A3014.md)
- 2012-09-30 to 2013-03-31 | quarterly_research_and_development | 5,753,000 United States dollar | superseded | [clm_5621727A37B2](/claim/clm_5621727A37B2.md)
- 2012-09-30 to 2012-12-31 | total_equity | 142,956,000 United States dollar | superseded | [clm_69A32727EF43](/claim/clm_69A32727EF43.md)
- 2012-09-30 to 2013-03-31 | quarterly_net_income | -2,011,000 United States dollar | superseded | [clm_95670867AE0C](/claim/clm_95670867AE0C.md)
- 2012-09-30 to 2013-03-31 | quarterly_revenue | 36,371,000 United States dollar | superseded | [clm_B5347767F344](/claim/clm_B5347767F344.md)
- 2012-09-30 to 2012-12-31 | cash_and_equivalents | 123,083,000 United States dollar | superseded | [clm_E2C591535F25](/claim/clm_E2C591535F25.md)
- 2012-12-31 to 2013-03-31 | total_assets | 187,696,000 United States dollar | superseded | [clm_2EDAF9B89B23](/claim/clm_2EDAF9B89B23.md)
- 2012-12-31 to 2013-12-31 | revenue | 137,567,000 United States dollar | superseded | [clm_3E5EACC45F5B](/claim/clm_3E5EACC45F5B.md)
- 2012-12-31 to 2013-12-31 | operating_income | -18,765,000 United States dollar | superseded | [clm_75D81946E91A](/claim/clm_75D81946E91A.md)
- 2012-12-31 to 2013-03-31 | total_equity | 165,662,000 United States dollar | superseded | [clm_B047497213FB](/claim/clm_B047497213FB.md)
- 2012-12-31 to 2013-12-31 | net_income | -19,113,000 United States dollar | superseded | [clm_BC80D8D35438](/claim/clm_BC80D8D35438.md)
- 2012-12-31 to 2013-12-31 | research_and_development | 20,473,000 United States dollar | superseded | [clm_C7F7EFF5F99D](/claim/clm_C7F7EFF5F99D.md)
- 2012-12-31 to 2013-03-31 | cash_and_equivalents | 95,124,000 United States dollar | superseded | [clm_E62D4E22A9CB](/claim/clm_E62D4E22A9CB.md)

## 2013

- 2013-03-31 to 2013-06-30 | quarterly_research_and_development | 7,236,000 United States dollar | superseded | [clm_1F9A9731A398](/claim/clm_1F9A9731A398.md)
- 2013-03-31 to 2013-06-30 | cash_and_equivalents | 94,498,000 United States dollar | superseded | [clm_5EA8E85D6AD9](/claim/clm_5EA8E85D6AD9.md)
- 2013-03-31 to 2013-06-30 | quarterly_operating_income | -4,554,000 United States dollar | superseded | [clm_94BA85432DC5](/claim/clm_94BA85432DC5.md)
- 2013-03-31 to 2013-06-30 | quarterly_net_income | -4,799,000 United States dollar | superseded | [clm_A1D9AEEB0562](/claim/clm_A1D9AEEB0562.md)
- 2013-03-31 to 2013-06-30 | total_assets | 187,294,000 United States dollar | superseded | [clm_B5F0CDA8D631](/claim/clm_B5F0CDA8D631.md)
- 2013-03-31 to 2013-06-30 | quarterly_revenue | 46,133,000 United States dollar | superseded | [clm_B94BBCE56632](/claim/clm_B94BBCE56632.md)
- 2013-03-31 to 2013-06-30 | total_equity | 165,434,000 United States dollar | superseded | [clm_E0B56950D0D8](/claim/clm_E0B56950D0D8.md)
- 2013-06-30 to 2013-09-30 | cash_and_equivalents | 96,795,000 United States dollar | superseded | [clm_5DBA71D53F67](/claim/clm_5DBA71D53F67.md)
- 2013-06-30 to 2013-09-30 | total_assets | 197,542,000 United States dollar | superseded | [clm_6629A2391697](/claim/clm_6629A2391697.md)
- 2013-06-30 to 2013-09-30 | quarterly_operating_income | -580,000 United States dollar | superseded | [clm_93A461828C17](/claim/clm_93A461828C17.md)
- 2013-06-30 to 2013-09-30 | quarterly_research_and_development | 7,997,000 United States dollar | superseded | [clm_9ABE90EDBD11](/claim/clm_9ABE90EDBD11.md)
- 2013-06-30 to 2013-09-30 | quarterly_revenue | 55,023,000 United States dollar | superseded | [clm_C105432B430F](/claim/clm_C105432B430F.md)
- 2013-06-30 to 2013-09-30 | total_equity | 174,497,000 United States dollar | superseded | [clm_C281AC62BBB3](/claim/clm_C281AC62BBB3.md)
- 2013-06-30 to 2013-09-30 | quarterly_net_income | -878,000 United States dollar | superseded | [clm_FF21326BCB26](/claim/clm_FF21326BCB26.md)
- 2013-09-30 to 2013-12-31 | cash_and_equivalents | 101,214,000 United States dollar | superseded | [clm_177A72021477](/claim/clm_177A72021477.md)
- 2013-09-30 to 2014-03-31 | quarterly_operating_income | -1,781,000 United States dollar | superseded | [clm_1DE1EFC85F84](/claim/clm_1DE1EFC85F84.md)
- 2013-09-30 to 2014-03-31 | quarterly_net_income | -2,322,000 United States dollar | superseded | [clm_9FF184B03670](/claim/clm_9FF184B03670.md)
- 2013-09-30 to 2013-12-31 | total_assets | 224,330,000 United States dollar | superseded | [clm_ADD6991F3FA8](/claim/clm_ADD6991F3FA8.md)
- 2013-09-30 to 2014-03-31 | quarterly_revenue | 61,181,000 United States dollar | superseded | [clm_AE4EF518062D](/claim/clm_AE4EF518062D.md)
- 2013-09-30 to 2014-03-31 | quarterly_research_and_development | 11,208,000 United States dollar | superseded | [clm_BC58851A4427](/claim/clm_BC58851A4427.md)
- 2013-09-30 to 2013-12-31 | total_equity | 196,431,000 United States dollar | superseded | [clm_CA5CE8785B8C](/claim/clm_CA5CE8785B8C.md)
- 2013-12-31 to 2014-12-31 | research_and_development | 38,243,000 United States dollar | superseded | [clm_392AFABCAAAA](/claim/clm_392AFABCAAAA.md)
- 2013-12-31 to 2014-03-31 | total_assets | 515,977,000 United States dollar | superseded | [clm_3FA1D0897D7E](/claim/clm_3FA1D0897D7E.md)
- 2013-12-31 to 2014-03-31 | total_equity | 486,483,000 United States dollar | superseded | [clm_5F6ACFBD56B4](/claim/clm_5F6ACFBD56B4.md)
- 2013-12-31 to 2014-12-31 | net_income | -10,068,000 United States dollar | superseded | [clm_70DEBB6A7548](/claim/clm_70DEBB6A7548.md)
- 2013-12-31 to 2014-12-31 | operating_income | -8,823,000 United States dollar | superseded | [clm_8D4544EE25AD](/claim/clm_8D4544EE25AD.md)
- 2013-12-31 to 2014-12-31 | revenue | 232,988,000 United States dollar | superseded | [clm_AC3AD28BEB9A](/claim/clm_AC3AD28BEB9A.md)
- 2013-12-31 to 2014-03-31 | cash_and_equivalents | 389,764,000 United States dollar | superseded | [clm_F98D5C9A5E63](/claim/clm_F98D5C9A5E63.md)

## 2014

- 2014-03-31 to 2014-06-30 | quarterly_revenue | 76,407,000 United States dollar | superseded | [clm_098D8D5AA216](/claim/clm_098D8D5AA216.md)
- 2014-03-31 to 2014-06-30 | total_equity | 499,936,000 United States dollar | superseded | [clm_2ECB4AB85430](/claim/clm_2ECB4AB85430.md)
- 2014-03-31 to 2014-06-30 | cash_and_equivalents | 399,320,000 United States dollar | superseded | [clm_326940822283](/claim/clm_326940822283.md)
- 2014-03-31 to 2014-06-30 | total_assets | 533,474,000 United States dollar | superseded | [clm_4A7F4EC3A054](/claim/clm_4A7F4EC3A054.md)
- 2014-03-31 to 2014-06-30 | quarterly_research_and_development | 13,982,000 United States dollar | superseded | [clm_8956070CE5EE](/claim/clm_8956070CE5EE.md)
- 2014-03-31 to 2014-06-30 | quarterly_operating_income | -4,604,000 United States dollar | superseded | [clm_CB22A16AFD5D](/claim/clm_CB22A16AFD5D.md)
- 2014-03-31 to 2014-06-30 | quarterly_net_income | -2,635,000 United States dollar | superseded | [clm_FE6001D0FA1D](/claim/clm_FE6001D0FA1D.md)
- 2014-06-30 to 2014-09-30 | quarterly_research_and_development | 14,726,000 United States dollar | superseded | [clm_2EAA7DEC2171](/claim/clm_2EAA7DEC2171.md)
- 2014-06-30 to 2014-09-30 | quarterly_net_income | 2,743,000 United States dollar | superseded | [clm_667097C46DC6](/claim/clm_667097C46DC6.md)
- 2014-06-30 to 2014-09-30 | cash_and_equivalents | 290,386,000 United States dollar | superseded | [clm_76BDF847D3C5](/claim/clm_76BDF847D3C5.md)
- 2014-06-30 to 2014-09-30 | quarterly_revenue | 88,787,000 United States dollar | superseded | [clm_80EE67963C62](/claim/clm_80EE67963C62.md)
- 2014-06-30 to 2014-09-30 | quarterly_operating_income | 3,127,000 United States dollar | superseded | [clm_AC62EF9AC991](/claim/clm_AC62EF9AC991.md)
- 2014-06-30 to 2014-09-30 | total_assets | 553,156,000 United States dollar | superseded | [clm_E4B9B1A441C9](/claim/clm_E4B9B1A441C9.md)
- 2014-06-30 to 2014-09-30 | total_equity | 521,245,000 United States dollar | superseded | [clm_F9D841C9D664](/claim/clm_F9D841C9D664.md)
- 2014-09-30 to 2014-12-31 | total_equity | 538,623,000 United States dollar | superseded | [clm_45EBFB944A8A](/claim/clm_45EBFB944A8A.md)
- 2014-09-30 to 2014-12-31 | total_assets | 577,399,000 United States dollar | superseded | [clm_48E8DEE47BA7](/claim/clm_48E8DEE47BA7.md)
- 2014-09-30 to 2015-03-31 | quarterly_net_income | 3,637,000 United States dollar | superseded | [clm_9B53A8210C81](/claim/clm_9B53A8210C81.md)
- 2014-09-30 to 2015-03-31 | quarterly_revenue | 102,455,000 United States dollar | superseded | [clm_B2B7960C3C83](/claim/clm_B2B7960C3C83.md)
- 2014-09-30 to 2015-03-31 | quarterly_research_and_development | 17,397,000 United States dollar | superseded | [clm_CD8C03E6054C](/claim/clm_CD8C03E6054C.md)
- 2014-09-30 to 2014-12-31 | cash_and_equivalents | 290,567,000 United States dollar | superseded | [clm_E261B4EBC08E](/claim/clm_E261B4EBC08E.md)
- 2014-09-30 to 2015-03-31 | quarterly_operating_income | 4,544,000 United States dollar | superseded | [clm_F842EBA3974E](/claim/clm_F842EBA3974E.md)
- 2014-12-31 to 2015-12-31 | operating_income | 11,059,000 United States dollar | superseded | [clm_0028E5837495](/claim/clm_0028E5837495.md)
- 2014-12-31 to 2015-12-31 | revenue | 377,536,000 United States dollar | superseded | [clm_1C21D58980F5](/claim/clm_1C21D58980F5.md)
- 2014-12-31 to 2015-12-31 | net_income | 36,473,000 United States dollar | superseded | [clm_3FB5B7C137B0](/claim/clm_3FB5B7C137B0.md)
- 2014-12-31 to 2015-12-31 | research_and_development | 65,181,000 United States dollar | superseded | [clm_8444315018FD](/claim/clm_8444315018FD.md)
- 2014-12-31 to 2015-03-31 | cash_and_equivalents | 247,312,000 United States dollar | superseded | [clm_A690CAA5FFFE](/claim/clm_A690CAA5FFFE.md)
- 2014-12-31 to 2015-03-31 | total_equity | 588,150,000 United States dollar | superseded | [clm_D6B876E2BDFA](/claim/clm_D6B876E2BDFA.md)
- 2014-12-31 to 2015-03-31 | total_assets | 629,650,000 United States dollar | superseded | [clm_E02B17342B8E](/claim/clm_E02B17342B8E.md)

## 2015

- 2015-03-31 to 2015-06-30 | quarterly_revenue | 118,508,000 United States dollar | superseded | [clm_1D0FB9B6DCD6](/claim/clm_1D0FB9B6DCD6.md)
- 2015-03-31 to 2015-06-30 | cash_and_equivalents | 172,629,000 United States dollar | superseded | [clm_32E099377685](/claim/clm_32E099377685.md)
- 2015-03-31 to 2015-06-30 | quarterly_operating_income | -4,249,000 United States dollar | superseded | [clm_7108CEF99697](/claim/clm_7108CEF99697.md)
- 2015-03-31 to 2015-06-30 | quarterly_net_income | -1,284,000 United States dollar | superseded | [clm_8FBA3A57006D](/claim/clm_8FBA3A57006D.md)
- 2015-03-31 to 2015-06-30 | total_assets | 715,886,000 United States dollar | superseded | [clm_A9542E9A7A55](/claim/clm_A9542E9A7A55.md)
- 2015-03-31 to 2015-06-30 | quarterly_research_and_development | 23,960,000 United States dollar | superseded | [clm_AD5C2B7DAEE5](/claim/clm_AD5C2B7DAEE5.md)
- 2015-03-31 to 2015-06-30 | total_equity | 656,656,000 United States dollar | superseded | [clm_D4EF1C8E2C76](/claim/clm_D4EF1C8E2C76.md)
- 2015-06-30 to 2015-09-30 | quarterly_research_and_development | 26,345,000 United States dollar | superseded | [clm_318A467538BE](/claim/clm_318A467538BE.md)
- 2015-06-30 to 2015-09-30 | quarterly_operating_income | 50,000 United States dollar | superseded | [clm_39BE2EF26B06](/claim/clm_39BE2EF26B06.md)
- 2015-06-30 to 2015-09-30 | quarterly_net_income | -1,305,000 United States dollar | superseded | [clm_4937DC9EE55A](/claim/clm_4937DC9EE55A.md)
- 2015-06-30 to 2015-09-30 | total_equity | 686,165,000 United States dollar | superseded | [clm_4945555822C3](/claim/clm_4945555822C3.md)
- 2015-06-30 to 2015-09-30 | quarterly_revenue | 133,913,000 United States dollar | superseded | [clm_8EB3F9DEF1E9](/claim/clm_8EB3F9DEF1E9.md)
- 2015-06-30 to 2015-09-30 | cash_and_equivalents | 181,460,000 United States dollar | superseded | [clm_9D6CC5F634F9](/claim/clm_9D6CC5F634F9.md)
- 2015-06-30 to 2015-09-30 | total_assets | 741,387,000 United States dollar | superseded | [clm_EA52D787730A](/claim/clm_EA52D787730A.md)
- 2015-09-30 to 2015-12-31 | total_assets | 764,405,000 United States dollar | superseded | [clm_49D2500DD6E7](/claim/clm_49D2500DD6E7.md)
- 2015-09-30 to 2016-03-31 | quarterly_operating_income | -10,712,000 United States dollar | superseded | [clm_4BC9E9C9E60E](/claim/clm_4BC9E9C9E60E.md)
- 2015-09-30 to 2016-03-31 | quarterly_revenue | 143,559,000 United States dollar | superseded | [clm_5BECAF9C85C4](/claim/clm_5BECAF9C85C4.md)
- 2015-09-30 to 2015-12-31 | total_equity | 696,462,000 United States dollar | superseded | [clm_88CB08F6BD7A](/claim/clm_88CB08F6BD7A.md)
- 2015-09-30 to 2016-03-31 | quarterly_research_and_development | 28,511,000 United States dollar | superseded | [clm_9DC593CBFA63](/claim/clm_9DC593CBFA63.md)
- 2015-09-30 to 2015-12-31 | cash_and_equivalents | 171,807,000 United States dollar | superseded | [clm_AA7C962F5766](/claim/clm_AA7C962F5766.md)
- 2015-09-30 to 2016-03-31 | quarterly_net_income | -8,082,000 United States dollar | superseded | [clm_D76D3175B220](/claim/clm_D76D3175B220.md)
- 2015-12-31 to 2016-12-31 | revenue | 549,711,000 United States dollar | superseded | [clm_0D2F798C5621](/claim/clm_0D2F798C5621.md)
- 2015-12-31 to 2016-03-31 | cash_and_equivalents | 171,613,000 United States dollar | superseded | [clm_29712F4B1B8E](/claim/clm_29712F4B1B8E.md)
- 2015-12-31 to 2016-12-31 | net_income | -32,900,000 United States dollar | superseded | [clm_3B6F24B964AE](/claim/clm_3B6F24B964AE.md)
- 2015-12-31 to 2016-12-31 | operating_income | -21,324,000 United States dollar | superseded | [clm_9F84B776A24F](/claim/clm_9F84B776A24F.md)
- 2015-12-31 to 2016-03-31 | total_assets | 755,427,000 United States dollar | superseded | [clm_BCCEE9C6E15F](/claim/clm_BCCEE9C6E15F.md)
- 2015-12-31 to 2016-03-31 | total_equity | 693,620,000 United States dollar | superseded | [clm_C8566FFA53FB](/claim/clm_C8566FFA53FB.md)
- 2015-12-31 to 2016-12-31 | research_and_development | 107,786,000 United States dollar | superseded | [clm_FB0C2F9C9678](/claim/clm_FB0C2F9C9678.md)

## 2016

- 2016-03-31 to 2016-06-30 | cash_and_equivalents | 183,505,000 United States dollar | superseded | [clm_1E2B9448851B](/claim/clm_1E2B9448851B.md)
- 2016-03-31 to 2016-06-30 | quarterly_operating_income | -14,273,000 United States dollar | superseded | [clm_2F44E08A44D2](/claim/clm_2F44E08A44D2.md)
- 2016-03-31 to 2016-06-30 | quarterly_research_and_development | 32,222,000 United States dollar | superseded | [clm_3952EAE8BBA1](/claim/clm_3952EAE8BBA1.md)
- 2016-03-31 to 2016-06-30 | quarterly_revenue | 158,613,000 United States dollar | superseded | [clm_6DAEAC878EEB](/claim/clm_6DAEAC878EEB.md)
- 2016-03-31 to 2016-06-30 | quarterly_net_income | -15,452,000 United States dollar | superseded | [clm_79AE58065112](/claim/clm_79AE58065112.md)
- 2016-03-31 to 2016-06-30 | total_assets | 772,967,000 United States dollar | superseded | [clm_95CA1D6A4233](/claim/clm_95CA1D6A4233.md)
- 2016-03-31 to 2016-06-30 | total_equity | 700,694,000 United States dollar | superseded | [clm_F5A7F008D7E3](/claim/clm_F5A7F008D7E3.md)
- 2016-06-30 to 2016-09-30 | quarterly_revenue | 173,428,000 United States dollar | superseded | [clm_361FF7D084F3](/claim/clm_361FF7D084F3.md)
- 2016-06-30 to 2016-09-30 | total_assets | 799,798,000 United States dollar | superseded | [clm_7175BCECCEB3](/claim/clm_7175BCECCEB3.md)
- 2016-06-30 to 2016-09-30 | quarterly_net_income | 449,000 United States dollar | superseded | [clm_992040D1809C](/claim/clm_992040D1809C.md)
- 2016-06-30 to 2016-09-30 | quarterly_research_and_development | 33,098,000 United States dollar | superseded | [clm_9AC158DE0F25](/claim/clm_9AC158DE0F25.md)
- 2016-06-30 to 2016-09-30 | cash_and_equivalents | 196,295,000 United States dollar | superseded | [clm_B026D3A70115](/claim/clm_B026D3A70115.md)
- 2016-06-30 to 2016-09-30 | quarterly_operating_income | -1,187,000 United States dollar | superseded | [clm_FC563D3E7BF5](/claim/clm_FC563D3E7BF5.md)
- 2016-06-30 to 2016-09-30 | total_equity | 729,107,000 United States dollar | superseded | [clm_FF7A526200A7](/claim/clm_FF7A526200A7.md)
- 2016-09-30 to 2016-12-31 | total_assets | 845,588,000 United States dollar | superseded | [clm_31F0BEBD6DFD](/claim/clm_31F0BEBD6DFD.md)
- 2016-09-30 to 2017-03-31 | quarterly_operating_income | 1,960,000 United States dollar | superseded | [clm_4D88D95F970D](/claim/clm_4D88D95F970D.md)
- 2016-09-30 to 2016-12-31 | total_equity | 765,581,000 United States dollar | superseded | [clm_A093A4E6063B](/claim/clm_A093A4E6063B.md)
- 2016-09-30 to 2016-12-31 | cash_and_equivalents | 224,891,000 United States dollar | superseded | [clm_BB3C86CE220D](/claim/clm_BB3C86CE220D.md)
- 2016-09-30 to 2017-03-31 | quarterly_revenue | 186,232,000 United States dollar | superseded | [clm_D8924F513781](/claim/clm_D8924F513781.md)
- 2016-09-30 to 2017-03-31 | quarterly_net_income | 2,070,000 United States dollar | superseded | [clm_E27648E7299A](/claim/clm_E27648E7299A.md)
- 2016-09-30 to 2017-03-31 | quarterly_research_and_development | 36,369,000 United States dollar | superseded | [clm_FA73F6BF9D7F](/claim/clm_FA73F6BF9D7F.md)
- 2016-10-28 to 2017-02-23 | shares_outstanding | 78,457,418 shares | superseded | [clm_2135E98834A6](/claim/clm_2135E98834A6.md)
- 2016-12-31 to 2017-12-31 | operating_income | -4,979,000 United States dollar | superseded | [clm_19AC5802B58D](/claim/clm_19AC5802B58D.md)
- 2016-12-31 to 2017-12-31 | research_and_development | 138,549,000 United States dollar | superseded | [clm_27CE93276E80](/claim/clm_27CE93276E80.md)
- 2016-12-31 to 2017-12-31 | revenue | 716,063,000 United States dollar | superseded | [clm_2E6FDC8F006A](/claim/clm_2E6FDC8F006A.md)
- 2016-12-31 to 2017-03-31 | total_assets | 885,206,000 United States dollar | superseded | [clm_6B84D872C5E1](/claim/clm_6B84D872C5E1.md)
- 2016-12-31 to 2017-03-31 | total_equity | 807,186,000 United States dollar | superseded | [clm_7A7FEE0DCA1A](/claim/clm_7A7FEE0DCA1A.md)
- 2016-12-31 to 2017-03-31 | cash_and_equivalents | 272,201,000 United States dollar | superseded | [clm_7FFA99823079](/claim/clm_7FFA99823079.md)
- 2016-12-31 to 2017-12-31 | net_income | -4,670,000 United States dollar | superseded | [clm_AFFE16C670CF](/claim/clm_AFFE16C670CF.md)

## 2017

- 2017-02-23 to 2017-05-04 | shares_outstanding | 79,602,606 shares | superseded | [clm_2B64B9973282](/claim/clm_2B64B9973282.md)
- 2017-03-31 to 2017-06-30 | quarterly_operating_income | -5,445,000 United States dollar | superseded | [clm_071506283F6E](/claim/clm_071506283F6E.md)
- 2017-03-31 to 2017-06-30 | total_assets | 922,171,000 United States dollar | superseded | [clm_196BD7696AE5](/claim/clm_196BD7696AE5.md)
- 2017-03-31 to 2017-06-30 | total_equity | 831,935,000 United States dollar | superseded | [clm_3FF116C44495](/claim/clm_3FF116C44495.md)
- 2017-03-31 to 2017-06-30 | quarterly_revenue | 197,323,000 United States dollar | superseded | [clm_4D02E2B32827](/claim/clm_4D02E2B32827.md)
- 2017-03-31 to 2017-06-30 | cash_and_equivalents | 272,279,000 United States dollar | superseded | [clm_8A7386BB02A6](/claim/clm_8A7386BB02A6.md)
- 2017-03-31 to 2017-06-30 | quarterly_net_income | -4,780,000 United States dollar | superseded | [clm_E66B8F528CC7](/claim/clm_E66B8F528CC7.md)
- 2017-03-31 to 2017-06-30 | quarterly_research_and_development | 39,871,000 United States dollar | superseded | [clm_EEEADCD3F38A](/claim/clm_EEEADCD3F38A.md)
- 2017-05-04 to 2017-07-31 | shares_outstanding | 80,582,775 shares | superseded | [clm_55A660B6625B](/claim/clm_55A660B6625B.md)
- 2017-06-30 to 2017-09-30 | total_equity | 886,666,000 United States dollar | superseded | [clm_0CC53FAA8576](/claim/clm_0CC53FAA8576.md)
- 2017-06-30 to 2017-09-30 | quarterly_net_income | 7,590,000 United States dollar | superseded | [clm_110037AF4D63](/claim/clm_110037AF4D63.md)
- 2017-06-30 to 2017-09-30 | total_assets | 970,115,000 United States dollar | superseded | [clm_43C9C4657B15](/claim/clm_43C9C4657B15.md)
- 2017-06-30 to 2017-09-30 | quarterly_revenue | 208,864,000 United States dollar | superseded | [clm_566780D4C3F0](/claim/clm_566780D4C3F0.md)
- 2017-06-30 to 2017-09-30 | quarterly_research_and_development | 42,088,000 United States dollar | superseded | [clm_9A398E7A78A6](/claim/clm_9A398E7A78A6.md)
- 2017-06-30 to 2017-09-30 | cash_and_equivalents | 319,754,000 United States dollar | superseded | [clm_B1B8BA4897FF](/claim/clm_B1B8BA4897FF.md)
- 2017-06-30 to 2017-09-30 | quarterly_operating_income | 6,844,000 United States dollar | superseded | [clm_B8294EADF6C1](/claim/clm_B8294EADF6C1.md)
- 2017-07-31 to 2017-10-31 | shares_outstanding | 81,803,464 shares | superseded | [clm_7AB635DCA04F](/claim/clm_7AB635DCA04F.md)
- 2017-09-30 to 2018-03-31 | quarterly_operating_income | 6,808,000 United States dollar | superseded | [clm_1E02EDCDE5C9](/claim/clm_1E02EDCDE5C9.md)
- 2017-09-30 to 2018-03-31 | quarterly_research_and_development | 45,834,000 United States dollar | superseded | [clm_21534A1F0698](/claim/clm_21534A1F0698.md)
- 2017-09-30 to 2017-12-31 | total_equity | 925,296,000 United States dollar | superseded | [clm_48F3AA304857](/claim/clm_48F3AA304857.md)
- 2017-09-30 to 2017-12-31 | total_assets | 1,027,115,000 United States dollar | superseded | [clm_71B6406B4681](/claim/clm_71B6406B4681.md)
- 2017-09-30 to 2017-12-31 | cash_and_equivalents | 362,401,000 United States dollar | superseded | [clm_79F0F757BCB4](/claim/clm_79F0F757BCB4.md)
- 2017-09-30 to 2018-03-31 | quarterly_net_income | 7,947,000 United States dollar | superseded | [clm_9F733A09939A](/claim/clm_9F733A09939A.md)
- 2017-09-30 to 2018-03-31 | quarterly_revenue | 223,287,000 United States dollar | superseded | [clm_AECF45F864F9](/claim/clm_AECF45F864F9.md)
- 2017-10-31 to 2018-02-20 | shares_outstanding | 82,889,825 shares | superseded | [clm_18BCC4D77F75](/claim/clm_18BCC4D77F75.md)
- 2017-12-31 to 2018-12-31 | revenue | 850,847,000 United States dollar | superseded | [clm_38D42638D0C7](/claim/clm_38D42638D0C7.md)
- 2017-12-31 to 2018-12-31 | operating_income | 179,485,000 United States dollar | superseded | [clm_784F46078D0A](/claim/clm_784F46078D0A.md)
- 2017-12-31 to 2018-03-31 | total_equity | 1,099,608,000 United States dollar | superseded | [clm_797957E2BD00](/claim/clm_797957E2BD00.md)
- 2017-12-31 to 2018-12-31 | net_income | 152,858,000 United States dollar | superseded | [clm_7CF182C3F548](/claim/clm_7CF182C3F548.md)
- 2017-12-31 to 2018-03-31 | cash_and_equivalents | 547,850,000 United States dollar | superseded | [clm_9B41B568AF57](/claim/clm_9B41B568AF57.md)
- 2017-12-31 to 2018-12-31 | research_and_development | 171,200,000 United States dollar | superseded | [clm_A03077383F98](/claim/clm_A03077383F98.md)
- 2017-12-31 to 2018-03-31 | total_assets | 1,216,512,000 United States dollar | superseded | [clm_DAB31DCB5865](/claim/clm_DAB31DCB5865.md)

## 2018

- 2018-02-20 to 2018-05-01 | shares_outstanding | 83,474,973 shares | superseded | [clm_B5B9F24C97C7](/claim/clm_B5B9F24C97C7.md)
- 2018-03-31 to 2018-06-30 | total_equity | 1,092,153,000 United States dollar | superseded | [clm_34402A46D02E](/claim/clm_34402A46D02E.md)
- 2018-03-31 to 2018-06-30 | total_assets | 1,218,499,000 United States dollar | superseded | [clm_41BE9FF9F472](/claim/clm_41BE9FF9F472.md)
- 2018-03-31 to 2018-06-30 | cash_and_equivalents | 392,335,000 United States dollar | superseded | [clm_4AA01B001FCB](/claim/clm_4AA01B001FCB.md)
- 2018-03-31 to 2018-06-30 | quarterly_operating_income | -4,827,000 United States dollar | superseded | [clm_AA06C9F6B652](/claim/clm_AA06C9F6B652.md)
- 2018-03-31 to 2018-06-30 | quarterly_research_and_development | 51,493,000 United States dollar | superseded | [clm_B9617D6F5319](/claim/clm_B9617D6F5319.md)
- 2018-03-31 to 2018-06-30 | quarterly_net_income | -2,286,000 United States dollar | superseded | [clm_C2406D0260DD](/claim/clm_C2406D0260DD.md)
- 2018-03-31 to 2018-06-30 | quarterly_revenue | 223,074,000 United States dollar | superseded | [clm_C38E47FECED0](/claim/clm_C38E47FECED0.md)
- 2018-05-01 to 2018-07-31 | shares_outstanding | 83,657,627 shares | superseded | [clm_DCEEA697C226](/claim/clm_DCEEA697C226.md)
- 2018-06-30 to 2018-09-30 | quarterly_net_income | 10,704,000 United States dollar | superseded | [clm_2C6D67753DBC](/claim/clm_2C6D67753DBC.md)
- 2018-06-30 to 2018-09-30 | quarterly_revenue | 234,863,000 United States dollar | superseded | [clm_3760E4C6971F](/claim/clm_3760E4C6971F.md)
- 2018-06-30 to 2018-09-30 | total_assets | 1,198,224,000 United States dollar | superseded | [clm_38797B8A1720](/claim/clm_38797B8A1720.md)
- 2018-06-30 to 2018-09-30 | quarterly_research_and_development | 52,789,000 United States dollar | superseded | [clm_51C14847EC32](/claim/clm_51C14847EC32.md)
- 2018-06-30 to 2018-09-30 | total_equity | 1,098,434,000 United States dollar | superseded | [clm_6B1F19951AB7](/claim/clm_6B1F19951AB7.md)
- 2018-06-30 to 2018-09-30 | cash_and_equivalents | 389,416,000 United States dollar | superseded | [clm_B228AC631D60](/claim/clm_B228AC631D60.md)
- 2018-06-30 to 2018-09-30 | quarterly_operating_income | 7,621,000 United States dollar | superseded | [clm_B2FFB0E2AFDF](/claim/clm_B2FFB0E2AFDF.md)
- 2018-07-31 to 2018-10-31 | shares_outstanding | 83,675,059 shares | superseded | [clm_663A6A41F015](/claim/clm_663A6A41F015.md)
- 2018-09-30 to 2019-03-31 | quarterly_revenue | 241,096,000 United States dollar | superseded | [clm_0E248B9BE3B9](/claim/clm_0E248B9BE3B9.md)
- 2018-09-30 to 2019-03-31 | quarterly_operating_income | 10,381,000 United States dollar | superseded | [clm_3EA33729814C](/claim/clm_3EA33729814C.md)
- 2018-09-30 to 2018-12-31 | total_equity | 1,129,494,000 United States dollar | superseded | [clm_61FD0EDEC53E](/claim/clm_61FD0EDEC53E.md)
- 2018-09-30 to 2018-12-31 | total_assets | 1,233,257,000 United States dollar | superseded | [clm_CB7CB00E9F3A](/claim/clm_CB7CB00E9F3A.md)
- 2018-09-30 to 2018-12-31 | cash_and_equivalents | 423,495,000 United States dollar | superseded | [clm_D7CCEC2816FE](/claim/clm_D7CCEC2816FE.md)
- 2018-09-30 to 2019-03-31 | quarterly_research_and_development | 53,764,000 United States dollar | superseded | [clm_E83E9705DB74](/claim/clm_E83E9705DB74.md)
- 2018-09-30 to 2019-03-31 | quarterly_net_income | 14,986,000 United States dollar | superseded | [clm_EE04224E0D2D](/claim/clm_EE04224E0D2D.md)
- 2018-10-31 to 2019-02-20 | shares_outstanding | 83,083,501 shares | superseded | [clm_D90827866EEF](/claim/clm_D90827866EEF.md)
- 2018-12-31 to 2019-12-31 | research_and_development | 205,800,000 United States dollar | superseded | [clm_69320EA2DDAC](/claim/clm_69320EA2DDAC.md)
- 2018-12-31 to 2019-12-31 | net_income | 55,350,000 United States dollar | superseded | [clm_6DB9AC0CEFAB](/claim/clm_6DB9AC0CEFAB.md)
- 2018-12-31 to 2019-03-31 | cash_and_equivalents | 332,764,000 United States dollar | superseded | [clm_87A8D7AF53AF](/claim/clm_87A8D7AF53AF.md)
- 2018-12-31 to 2019-12-31 | revenue | 942,773,000 United States dollar | superseded | [clm_9875C20A7509](/claim/clm_9875C20A7509.md)
- 2018-12-31 to 2019-12-31 | operating_income | 25,897,000 United States dollar | superseded | [clm_A5A7DEBFA028](/claim/clm_A5A7DEBFA028.md)
- 2018-12-31 to 2019-03-31 | total_assets | 1,175,563,000 United States dollar | superseded | [clm_B1D8D844D568](/claim/clm_B1D8D844D568.md)
- 2018-12-31 to 2019-03-31 | total_equity | 1,075,518,000 United States dollar | superseded | [clm_CF528CB89D5B](/claim/clm_CF528CB89D5B.md)

## 2019

- 2019-02-20 to 2019-04-30 | shares_outstanding | 82,025,023 shares | superseded | [clm_B421909E0A0F](/claim/clm_B421909E0A0F.md)
- 2019-03-31 to 2019-06-30 | cash_and_equivalents | 295,276,000 United States dollar | superseded | [clm_09C1B8B86439](/claim/clm_09C1B8B86439.md)
- 2019-03-31 to 2019-06-30 | total_equity | 994,838,000 United States dollar | superseded | [clm_34E45EE96829](/claim/clm_34E45EE96829.md)
- 2019-03-31 to 2019-06-30 | quarterly_operating_income | -3,882,000 United States dollar | superseded | [clm_49536BC56E4C](/claim/clm_49536BC56E4C.md)
- 2019-03-31 to 2019-06-30 | quarterly_net_income | 1,365,000 United States dollar | superseded | [clm_815BD8EE7682](/claim/clm_815BD8EE7682.md)
- 2019-03-31 to 2019-06-30 | total_assets | 1,337,860,000 United States dollar | superseded | [clm_83AE7A10DBE6](/claim/clm_83AE7A10DBE6.md)
- 2019-03-31 to 2019-06-30 | quarterly_research_and_development | 58,075,000 United States dollar | superseded | [clm_BDC43BF2F3CF](/claim/clm_BDC43BF2F3CF.md)
- 2019-03-31 to 2019-06-30 | quarterly_revenue | 235,942,000 United States dollar | superseded | [clm_D93A16BB3390](/claim/clm_D93A16BB3390.md)
- 2019-04-30 to 2019-08-02 | shares_outstanding | 77,270,111 shares | superseded | [clm_9561FDB7332D](/claim/clm_9561FDB7332D.md)
- 2019-06-30 to 2019-09-30 | quarterly_net_income | 12,303,000 United States dollar | superseded | [clm_24D0E1FE095A](/claim/clm_24D0E1FE095A.md)
- 2019-06-30 to 2019-09-30 | total_equity | 746,455,000 United States dollar | superseded | [clm_58D87322099B](/claim/clm_58D87322099B.md)
- 2019-06-30 to 2019-09-30 | total_assets | 1,083,433,000 United States dollar | superseded | [clm_7F1B8753AB15](/claim/clm_7F1B8753AB15.md)
- 2019-06-30 to 2019-09-30 | quarterly_operating_income | 12,197,000 United States dollar | superseded | [clm_B23982392676](/claim/clm_B23982392676.md)
- 2019-06-30 to 2019-09-30 | quarterly_revenue | 246,955,000 United States dollar | superseded | [clm_BE26741B4B5E](/claim/clm_BE26741B4B5E.md)
- 2019-06-30 to 2019-09-30 | quarterly_research_and_development | 54,566,000 United States dollar | superseded | [clm_C1E4FD7D0568](/claim/clm_C1E4FD7D0568.md)
- 2019-06-30 to 2019-09-30 | cash_and_equivalents | 139,464,000 United States dollar | superseded | [clm_FF7AC58FBD1F](/claim/clm_FF7AC58FBD1F.md)
- 2019-08-02 to 2019-10-31 | shares_outstanding | 71,027,519 shares | superseded | [clm_3E443F9D0EAD](/claim/clm_3E443F9D0EAD.md)
- 2019-09-30 to 2020-03-31 | quarterly_net_income | 10,061,000 United States dollar | superseded | [clm_04FA98A47331](/claim/clm_04FA98A47331.md)
- 2019-09-30 to 2019-12-31 | total_equity | 702,564,000 United States dollar | superseded | [clm_0A7F911B0D96](/claim/clm_0A7F911B0D96.md)
- 2019-09-30 to 2020-03-31 | quarterly_research_and_development | 56,661,000 United States dollar | superseded | [clm_0BEA89701DDF](/claim/clm_0BEA89701DDF.md)
- 2019-09-30 to 2020-03-31 | quarterly_revenue | 262,474,000 United States dollar | superseded | [clm_0F9A4815119E](/claim/clm_0F9A4815119E.md)
- 2019-09-30 to 2020-03-31 | quarterly_operating_income | 9,550,000 United States dollar | superseded | [clm_3DAEE66D6646](/claim/clm_3DAEE66D6646.md)
- 2019-09-30 to 2019-12-31 | total_assets | 1,028,769,000 United States dollar | superseded | [clm_829438911C88](/claim/clm_829438911C88.md)
- 2019-09-30 to 2019-12-31 | cash_and_equivalents | 123,402,000 United States dollar | superseded | [clm_C058B89141C7](/claim/clm_C058B89141C7.md)
- 2019-10-31 to 2020-02-21 | shares_outstanding | 70,201,693 shares | superseded | [clm_45C7E6FB85D8](/claim/clm_45C7E6FB85D8.md)
- 2019-12-31 to 2020-12-31 | revenue | 1,014,194,000 United States dollar | superseded | [clm_19868ACB0ADE](/claim/clm_19868ACB0ADE.md)
- 2019-12-31 to 2020-12-31 | net_income | 40,881,000 United States dollar | superseded | [clm_2C8264F36EE2](/claim/clm_2C8264F36EE2.md)
- 2019-12-31 to 2020-12-31 | operating_income | 35,511,000 United States dollar | superseded | [clm_324CA705D2B1](/claim/clm_324CA705D2B1.md)
- 2019-12-31 to 2020-03-31 | total_assets | 1,070,700,000 United States dollar | superseded | [clm_5D8BD55D86C9](/claim/clm_5D8BD55D86C9.md)
- 2019-12-31 to 2020-12-31 | research_and_development | 225,500,000 United States dollar | superseded | [clm_6889DF6FAED8](/claim/clm_6889DF6FAED8.md)
- 2019-12-31 to 2020-03-31 | cash_and_equivalents | 170,281,000 United States dollar | superseded | [clm_930DCDD60D8B](/claim/clm_930DCDD60D8B.md)
- 2019-12-31 to 2020-03-31 | total_equity | 754,991,000 United States dollar | superseded | [clm_E7901AD20FE2](/claim/clm_E7901AD20FE2.md)

## 2020

- 2020-02-21 to 2020-05-01 | shares_outstanding | 71,839,649 shares | superseded | [clm_A93344DFBD22](/claim/clm_A93344DFBD22.md)
- 2020-03-31 to 2020-06-30 | quarterly_net_income | -15,503,000 United States dollar | superseded | [clm_25A4B60E7C86](/claim/clm_25A4B60E7C86.md)
- 2020-03-31 to 2020-06-30 | total_equity | 762,432,000 United States dollar | superseded | [clm_4064B07B73B6](/claim/clm_4064B07B73B6.md)
- 2020-03-31 to 2020-06-30 | total_assets | 1,085,224,000 United States dollar | superseded | [clm_4D252F457BA6](/claim/clm_4D252F457BA6.md)
- 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 67,113,000 United States dollar | superseded | [clm_68DA53D1FB50](/claim/clm_68DA53D1FB50.md)
- 2020-03-31 to 2020-06-30 | quarterly_operating_income | -27,250,000 United States dollar | superseded | [clm_8236BDE4F709](/claim/clm_8236BDE4F709.md)
- 2020-03-31 to 2020-06-30 | quarterly_revenue | 249,901,000 United States dollar | superseded | [clm_BCCDAEB778A9](/claim/clm_BCCDAEB778A9.md)
- 2020-03-31 to 2020-06-30 | cash_and_equivalents | 364,576,000 United States dollar | superseded | [clm_EFBD10D1C998](/claim/clm_EFBD10D1C998.md)
- 2020-05-01 to 2020-07-31 | shares_outstanding | 71,889,796 shares | superseded | [clm_3FCDCC1E1C16](/claim/clm_3FCDCC1E1C16.md)
- 2020-06-30 to 2020-09-30 | total_assets | 1,073,485,000 United States dollar | superseded | [clm_07A8420A5935](/claim/clm_07A8420A5935.md)
- 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 53,969,000 United States dollar | superseded | [clm_0D2F4639746C](/claim/clm_0D2F4639746C.md)
- 2020-06-30 to 2020-09-30 | quarterly_net_income | -23,990,000 United States dollar | superseded | [clm_14681F91BFD7](/claim/clm_14681F91BFD7.md)
- 2020-06-30 to 2020-09-30 | total_equity | 781,320,000 United States dollar | superseded | [clm_3231DC14DBC0](/claim/clm_3231DC14DBC0.md)
- 2020-06-30 to 2020-09-30 | quarterly_revenue | 169,030,000 United States dollar | superseded | [clm_3C90F1728C9F](/claim/clm_3C90F1728C9F.md)
- 2020-06-30 to 2020-09-30 | cash_and_equivalents | 525,693,000 United States dollar | superseded | [clm_6FE44865ADC7](/claim/clm_6FE44865ADC7.md)
- 2020-06-30 to 2020-09-30 | quarterly_operating_income | -35,349,000 United States dollar | superseded | [clm_C420D0892327](/claim/clm_C420D0892327.md)
- 2020-07-31 to 2020-10-30 | shares_outstanding | 73,132,105 shares | superseded | [clm_218E825633D5](/claim/clm_218E825633D5.md)
- 2020-09-30 to 2020-12-31 | total_equity | 815,628,000 United States dollar | superseded | [clm_10CE1BD94113](/claim/clm_10CE1BD94113.md)
- 2020-09-30 to 2021-03-31 | quarterly_revenue | 220,807,000 United States dollar | superseded | [clm_1402A58E1705](/claim/clm_1402A58E1705.md)
- 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 53,022,000 United States dollar | superseded | [clm_1C440B44297C](/claim/clm_1C440B44297C.md)
- 2020-09-30 to 2020-12-31 | cash_and_equivalents | 590,789,000 United States dollar | superseded | [clm_2DB2FCC64D1B](/claim/clm_2DB2FCC64D1B.md)
- 2020-09-30 to 2021-03-31 | quarterly_operating_income | 9,325,000 United States dollar | superseded | [clm_4C2CF81510C1](/claim/clm_4C2CF81510C1.md)
- 2020-09-30 to 2020-12-31 | total_assets | 1,138,950,000 United States dollar | superseded | [clm_76451AE3AD47](/claim/clm_76451AE3AD47.md)
- 2020-09-30 to 2021-03-31 | quarterly_net_income | -1,020,000 United States dollar | superseded | [clm_ED3C8EDCE063](/claim/clm_ED3C8EDCE063.md)
- 2020-10-30 to 2021-02-19 | shares_outstanding | 73,996,090 shares | superseded | [clm_33BEF61CCB51](/claim/clm_33BEF61CCB51.md)
- 2020-12-31 to 2021-12-31 | operating_income | -38,795,000 United States dollar | superseded | [clm_0568C638C138](/claim/clm_0568C638C138.md)
- 2020-12-31 to 2021-12-31 | research_and_development | 230,100,000 United States dollar | superseded | [clm_26681AF0D4E4](/claim/clm_26681AF0D4E4.md)
- 2020-12-31 to 2021-03-31 | total_equity | 854,534,000 United States dollar | superseded | [clm_607A57DD8938](/claim/clm_607A57DD8938.md)
- 2020-12-31 to 2021-12-31 | revenue | 872,933,000 United States dollar | superseded | [clm_7490D9C950E3](/claim/clm_7490D9C950E3.md)
- 2020-12-31 to 2021-12-31 | net_income | -19,424,000 United States dollar | superseded | [clm_7F5B6596C0F3](/claim/clm_7F5B6596C0F3.md)
- 2020-12-31 to 2021-03-31 | total_assets | 1,154,947,000 United States dollar | superseded | [clm_8E468C791127](/claim/clm_8E468C791127.md)
- 2020-12-31 to 2021-03-31 | cash_and_equivalents | 595,875,000 United States dollar | superseded | [clm_C1B1CDC20973](/claim/clm_C1B1CDC20973.md)

## 2021

- 2021-02-19 to 2021-04-30 | shares_outstanding | 74,930,522 shares | superseded | [clm_9C9CD5C65FB8](/claim/clm_9C9CD5C65FB8.md)
- 2021-03-31 to 2021-06-30 | quarterly_revenue | 232,096,000 United States dollar | superseded | [clm_4F1401383ACC](/claim/clm_4F1401383ACC.md)
- 2021-03-31 to 2021-06-30 | quarterly_operating_income | -8,643,000 United States dollar | superseded | [clm_511AE9E34F3E](/claim/clm_511AE9E34F3E.md)
- 2021-03-31 to 2021-06-30 | total_equity | 827,100,000 United States dollar | superseded | [clm_628713882213](/claim/clm_628713882213.md)
- 2021-03-31 to 2021-06-30 | total_assets | 1,135,378,000 United States dollar | superseded | [clm_72D3421F90F5](/claim/clm_72D3421F90F5.md)
- 2021-03-31 to 2021-06-30 | cash_and_equivalents | 588,592,000 United States dollar | superseded | [clm_79DF0E3BED26](/claim/clm_79DF0E3BED26.md)
- 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 67,992,000 United States dollar | superseded | [clm_8721802D3FD8](/claim/clm_8721802D3FD8.md)
- 2021-03-31 to 2021-06-30 | quarterly_net_income | -5,796,000 United States dollar | superseded | [clm_B47203382CCF](/claim/clm_B47203382CCF.md)
- 2021-04-30 to 2021-08-03 | shares_outstanding | 74,497,869 shares | superseded | [clm_0880D5ACF3D8](/claim/clm_0880D5ACF3D8.md)
- 2021-06-30 to 2021-09-30 | quarterly_revenue | 257,188,000 United States dollar | superseded | [clm_4AD12F31BD90](/claim/clm_4AD12F31BD90.md)
- 2021-06-30 to 2021-09-30 | quarterly_net_income | 4,212,000 United States dollar | superseded | [clm_540ED803CD43](/claim/clm_540ED803CD43.md)
- 2021-06-30 to 2021-09-30 | cash_and_equivalents | 558,227,000 United States dollar | superseded | [clm_5BCB39BC91DF](/claim/clm_5BCB39BC91DF.md)
- 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 68,695,000 United States dollar | superseded | [clm_C85F1120D8D8](/claim/clm_C85F1120D8D8.md)
- 2021-06-30 to 2021-09-30 | total_equity | 803,464,000 United States dollar | superseded | [clm_D629C97B0DEF](/claim/clm_D629C97B0DEF.md)
- 2021-06-30 to 2021-09-30 | quarterly_operating_income | -1,081,000 United States dollar | superseded | [clm_E03D2734CDEF](/claim/clm_E03D2734CDEF.md)
- 2021-06-30 to 2021-09-30 | total_assets | 1,105,244,000 United States dollar | superseded | [clm_E218E23AC905](/claim/clm_E218E23AC905.md)
- 2021-08-03 to 2021-10-29 | shares_outstanding | 73,564,964 shares | superseded | [clm_36B5CDD34271](/claim/clm_36B5CDD34271.md)
- 2021-09-30 | quarterly_research_and_development | 69,402,000 United States dollar | valid | [clm_44BF336F3C7A](/claim/clm_44BF336F3C7A.md)
- 2021-09-30 to 2022-03-31 | quarterly_net_income | 18,065,000 United States dollar | superseded | [clm_AA8B657E95B4](/claim/clm_AA8B657E95B4.md)
- 2021-09-30 to 2022-03-31 | quarterly_operating_income | 21,645,000 United States dollar | superseded | [clm_B5421727A962](/claim/clm_B5421727A962.md)
- 2021-09-30 to 2021-12-31 | total_equity | 781,823,000 United States dollar | superseded | [clm_CD0BB34ADED7](/claim/clm_CD0BB34ADED7.md)
- 2021-09-30 to 2021-12-31 | cash_and_equivalents | 531,620,000 United States dollar | superseded | [clm_D8C41F5DF5FE](/claim/clm_D8C41F5DF5FE.md)
- 2021-09-30 to 2021-12-31 | total_assets | 1,079,068,000 United States dollar | superseded | [clm_F378BC22341C](/claim/clm_F378BC22341C.md)
- 2021-09-30 to 2022-03-31 | quarterly_revenue | 269,155,000 United States dollar | superseded | [clm_F39C34A548E9](/claim/clm_F39C34A548E9.md)
- 2021-10-29 to 2022-02-18 | shares_outstanding | 73,016,049 shares | superseded | [clm_1FD585CC66DC](/claim/clm_1FD585CC66DC.md)
- 2021-12-31 to 2022-12-31 | operating_income | 31,514,000 United States dollar | superseded | [clm_037CAC45F8D0](/claim/clm_037CAC45F8D0.md)
- 2021-12-31 to 2022-12-31 | research_and_development | 265,200,000 United States dollar | superseded | [clm_24060092CB94](/claim/clm_24060092CB94.md)
- 2021-12-31 to 2022-03-31 | cash_and_equivalents | 479,783,000 United States dollar | superseded | [clm_3547168F9B72](/claim/clm_3547168F9B72.md)
- 2021-12-31 to 2022-03-31 | total_equity | 751,318,000 United States dollar | superseded | [clm_60F8AEDABA0B](/claim/clm_60F8AEDABA0B.md)
- 2021-12-31 to 2022-12-31 | net_income | 39,671,000 United States dollar | superseded | [clm_8F67390DE402](/claim/clm_8F67390DE402.md)
- 2021-12-31 to 2022-12-31 | revenue | 1,031,839,000 United States dollar | superseded | [clm_9C1C2F1CAA92](/claim/clm_9C1C2F1CAA92.md)
- 2021-12-31 to 2022-03-31 | total_assets | 1,050,528,000 United States dollar | superseded | [clm_DBA6819AD51E](/claim/clm_DBA6819AD51E.md)

## 2022

- 2022-02-18 to 2022-04-29 | shares_outstanding | 71,104,767 shares | superseded | [clm_B883F3AED014](/claim/clm_B883F3AED014.md)
- 2022-03-31 to 2022-06-30 | quarterly_net_income | -915,000 United States dollar | superseded | [clm_39482F146187](/claim/clm_39482F146187.md)
- 2022-03-31 to 2022-06-30 | cash_and_equivalents | 465,121,000 United States dollar | superseded | [clm_3DB64C1FC4E3](/claim/clm_3DB64C1FC4E3.md)
- 2022-03-31 to 2022-06-30 | quarterly_operating_income | -4,456,000 United States dollar | superseded | [clm_5E572931FAA1](/claim/clm_5E572931FAA1.md)
- 2022-03-31 to 2022-06-30 | quarterly_revenue | 276,628,000 United States dollar | superseded | [clm_985374418B10](/claim/clm_985374418B10.md)
- 2022-03-31 to 2022-06-30 | total_assets | 1,044,906,000 United States dollar | superseded | [clm_DDD313A984D0](/claim/clm_DDD313A984D0.md)
- 2022-03-31 to 2022-06-30 | total_equity | 724,349,000 United States dollar | superseded | [clm_E84D76C3DEC1](/claim/clm_E84D76C3DEC1.md)
- 2022-04-29 to 2022-07-29 | shares_outstanding | 70,859,229 shares | superseded | [clm_B1EB1DD827C7](/claim/clm_B1EB1DD827C7.md)
- 2022-06-30 to 2022-09-30 | quarterly_net_income | 8,009,000 United States dollar | superseded | [clm_24DB0528CDC3](/claim/clm_24DB0528CDC3.md)
- 2022-06-30 to 2022-09-30 | cash_and_equivalents | 421,162,000 United States dollar | superseded | [clm_350AB11BE625](/claim/clm_350AB11BE625.md)
- 2022-06-30 to 2022-09-30 | total_equity | 718,604,000 United States dollar | superseded | [clm_8E729BB26EDF](/claim/clm_8E729BB26EDF.md)
- 2022-06-30 to 2022-09-30 | quarterly_operating_income | 16,001,000 United States dollar | superseded | [clm_906F678E82F5](/claim/clm_906F678E82F5.md)
- 2022-06-30 to 2022-09-30 | total_assets | 1,023,168,000 United States dollar | superseded | [clm_92D64E463E44](/claim/clm_92D64E463E44.md)
- 2022-06-30 to 2022-09-30 | quarterly_revenue | 298,884,000 United States dollar | superseded | [clm_ED7DA327F2A5](/claim/clm_ED7DA327F2A5.md)
- 2022-07-29 to 2022-11-01 | shares_outstanding | 70,273,827 shares | superseded | [clm_0732E26FEC94](/claim/clm_0732E26FEC94.md)
- 2022-09-30 to 2023-03-31 | quarterly_operating_income | 13,424,000 United States dollar | superseded | [clm_04E01891732A](/claim/clm_04E01891732A.md)
- 2022-09-30 to 2022-12-31 | total_equity | 701,378,000 United States dollar | superseded | [clm_7843D8696A52](/claim/clm_7843D8696A52.md)
- 2022-09-30 to 2022-12-31 | total_assets | 1,030,334,000 United States dollar | superseded | [clm_8E714B2FABBE](/claim/clm_8E714B2FABBE.md)
- 2022-09-30 to 2023-03-31 | quarterly_net_income | 9,108,000 United States dollar | superseded | [clm_9B6D4814632F](/claim/clm_9B6D4814632F.md)
- 2022-09-30 to 2023-03-31 | quarterly_revenue | 308,891,000 United States dollar | superseded | [clm_D4CD9BD2B486](/claim/clm_D4CD9BD2B486.md)
- 2022-09-30 to 2022-12-31 | cash_and_equivalents | 330,970,000 United States dollar | superseded | [clm_F7965281E76A](/claim/clm_F7965281E76A.md)
- 2022-11-01 to 2023-02-17 | shares_outstanding | 69,702,309 shares | superseded | [clm_3195ACC4BA46](/claim/clm_3195ACC4BA46.md)
- 2022-12-31 to 2023-12-31 | revenue | 1,193,506,000 United States dollar | superseded | [clm_09710C1DCA21](/claim/clm_09710C1DCA21.md)
- 2022-12-31 to 2023-03-31 | total_equity | 710,324,000 United States dollar | superseded | [clm_12CA0E4F6B90](/claim/clm_12CA0E4F6B90.md)
- 2022-12-31 to 2023-03-31 | total_assets | 1,015,922,000 United States dollar | superseded | [clm_3ECEF9AB7E78](/claim/clm_3ECEF9AB7E78.md)
- 2022-12-31 to 2023-12-31 | net_income | 36,347,000 United States dollar | superseded | [clm_5256E0F848DA](/claim/clm_5256E0F848DA.md)
- 2022-12-31 to 2023-12-31 | research_and_development | 294,500,000 United States dollar | superseded | [clm_59CE6073EA56](/claim/clm_59CE6073EA56.md)
- 2022-12-31 to 2023-03-31 | cash_and_equivalents | 306,379,000 United States dollar | superseded | [clm_DB4C820F3E85](/claim/clm_DB4C820F3E85.md)
- 2022-12-31 to 2023-12-31 | operating_income | 58,353,000 United States dollar | superseded | [clm_F6270CFA6384](/claim/clm_F6270CFA6384.md)

## 2023

- 2023-02-17 to 2023-04-28 | shares_outstanding | 69,543,177 shares | superseded | [clm_772E5C0A1759](/claim/clm_772E5C0A1759.md)
- 2023-03-31 to 2023-06-30 | total_equity | 704,128,000 United States dollar | superseded | [clm_5E99B90040E4](/claim/clm_5E99B90040E4.md)
- 2023-03-31 to 2023-06-30 | quarterly_revenue | 312,438,000 United States dollar | superseded | [clm_766F39EB95F7](/claim/clm_766F39EB95F7.md)
- 2023-03-31 to 2023-06-30 | cash_and_equivalents | 289,298,000 United States dollar | superseded | [clm_77650C50C54F](/claim/clm_77650C50C54F.md)
- 2023-03-31 to 2023-06-30 | quarterly_net_income | -1,178,000 United States dollar | superseded | [clm_A7E744E92BF4](/claim/clm_A7E744E92BF4.md)
- 2023-03-31 to 2023-06-30 | quarterly_operating_income | -6,587,000 United States dollar | superseded | [clm_AB8E87175EF6](/claim/clm_AB8E87175EF6.md)
- 2023-03-31 to 2023-06-30 | total_assets | 1,021,682,000 United States dollar | superseded | [clm_D8D1F3A5E417](/claim/clm_D8D1F3A5E417.md)
- 2023-04-28 to 2023-07-28 | shares_outstanding | 68,838,197 shares | superseded | [clm_8F1295A9F658](/claim/clm_8F1295A9F658.md)
- 2023-06-30 to 2023-09-30 | quarterly_revenue | 337,126,000 United States dollar | superseded | [clm_4C834BC12796](/claim/clm_4C834BC12796.md)
- 2023-06-30 to 2023-09-30 | quarterly_operating_income | 18,742,000 United States dollar | superseded | [clm_4FED391526EF](/claim/clm_4FED391526EF.md)
- 2023-06-30 to 2023-09-30 | total_equity | 708,602,000 United States dollar | superseded | [clm_6D009B4586C9](/claim/clm_6D009B4586C9.md)
- 2023-06-30 to 2023-09-30 | cash_and_equivalents | 270,256,000 United States dollar | superseded | [clm_8548C878AB5F](/claim/clm_8548C878AB5F.md)
- 2023-06-30 to 2023-09-30 | quarterly_net_income | 14,729,000 United States dollar | superseded | [clm_A26B09DAC1ED](/claim/clm_A26B09DAC1ED.md)
- 2023-06-30 to 2023-09-30 | total_assets | 1,033,288,000 United States dollar | superseded | [clm_F3F8C2B3587D](/claim/clm_F3F8C2B3587D.md)
- 2023-07-28 to 2023-10-27 | shares_outstanding | 68,713,576 shares | superseded | [clm_C0AE59459BF2](/claim/clm_C0AE59459BF2.md)
- 2023-09-30 to 2023-12-31 | total_equity | 739,574,000 United States dollar | superseded | [clm_2C5F540116D0](/claim/clm_2C5F540116D0.md)
- 2023-09-30 to 2024-03-31 | quarterly_operating_income | 41,873,000 United States dollar | superseded | [clm_4DFC02442D6B](/claim/clm_4DFC02442D6B.md)
- 2023-09-30 to 2024-03-31 | quarterly_revenue | 345,122,000 United States dollar | superseded | [clm_6DC8870E709B](/claim/clm_6DC8870E709B.md)
- 2023-09-30 to 2023-12-31 | cash_and_equivalents | 305,103,000 United States dollar | superseded | [clm_AB59BB0F4FB4](/claim/clm_AB59BB0F4FB4.md)
- 2023-09-30 to 2023-12-31 | total_assets | 1,027,318,000 United States dollar | superseded | [clm_B492E2DFC671](/claim/clm_B492E2DFC671.md)
- 2023-09-30 to 2024-03-31 | quarterly_net_income | 58,216,000 United States dollar | superseded | [clm_BE2094649BF5](/claim/clm_BE2094649BF5.md)
- 2023-10-27 to 2024-02-20 | shares_outstanding | 68,472,771 shares | superseded | [clm_0889C326A41D](/claim/clm_0889C326A41D.md)
- 2023-12-31 to 2024-12-31 | revenue | 1,337,062,000 United States dollar | superseded | [clm_1B9336898911](/claim/clm_1B9336898911.md)
- 2023-12-31 to 2024-12-31 | research_and_development | 320,600,000 United States dollar | superseded | [clm_63B3827781F4](/claim/clm_63B3827781F4.md)
- 2023-12-31 to 2024-03-31 | total_assets | 1,014,723,000 United States dollar | superseded | [clm_9377E432974F](/claim/clm_9377E432974F.md)
- 2023-12-31 to 2024-12-31 | operating_income | 79,043,000 United States dollar | superseded | [clm_966611D956B4](/claim/clm_966611D956B4.md)
- 2023-12-31 to 2024-03-31 | cash_and_equivalents | 313,911,000 United States dollar | superseded | [clm_CE246E0AE66E](/claim/clm_CE246E0AE66E.md)
- 2023-12-31 to 2024-03-31 | total_equity | 749,534,000 United States dollar | superseded | [clm_E328A146CC4D](/claim/clm_E328A146CC4D.md)
- 2023-12-31 to 2024-12-31 | net_income | 99,173,000 United States dollar | superseded | [clm_EC1F8C651688](/claim/clm_EC1F8C651688.md)

## 2024

- 2024-02-20 to 2024-05-03 | shares_outstanding | 68,281,153 shares | superseded | [clm_F6748DD0D450](/claim/clm_F6748DD0D450.md)
- 2024-03-31 to 2024-06-30 | quarterly_revenue | 332,752,000 United States dollar | superseded | [clm_6D49369A14BB](/claim/clm_6D49369A14BB.md)
- 2024-03-31 to 2024-06-30 | total_assets | 993,477,000 United States dollar | superseded | [clm_88B075F0D1DD](/claim/clm_88B075F0D1DD.md)
- 2024-03-31 to 2024-06-30 | total_equity | 721,973,000 United States dollar | superseded | [clm_9CDB6ED4161B](/claim/clm_9CDB6ED4161B.md)
- 2024-03-31 to 2024-06-30 | quarterly_net_income | 14,154,000 United States dollar | superseded | [clm_C54543B508D6](/claim/clm_C54543B508D6.md)
- 2024-03-31 to 2024-06-30 | quarterly_operating_income | 11,217,000 United States dollar | superseded | [clm_E155B7178B09](/claim/clm_E155B7178B09.md)
- 2024-03-31 to 2024-06-30 | cash_and_equivalents | 296,045,000 United States dollar | superseded | [clm_FC3C38C94411](/claim/clm_FC3C38C94411.md)
- 2024-05-03 to 2024-08-02 | shares_outstanding | 67,458,362 shares | superseded | [clm_796880B0C4B7](/claim/clm_796880B0C4B7.md)
- 2024-06-13 | board_member | Dan Jedda | valid | [clm_75DD9621A8CF](/claim/clm_75DD9621A8CF.md)
- 2024-06-30 to 2024-09-30 | quarterly_operating_income | 39,747,000 United States dollar | superseded | [clm_12326AD40E29](/claim/clm_12326AD40E29.md)
- 2024-06-30 to 2024-09-30 | total_equity | 735,347,000 United States dollar | superseded | [clm_4B34BB7DAE55](/claim/clm_4B34BB7DAE55.md)
- 2024-06-30 to 2024-09-30 | total_assets | 964,978,000 United States dollar | superseded | [clm_66206B41F582](/claim/clm_66206B41F582.md)
- 2024-06-30 to 2024-09-30 | quarterly_net_income | 38,036,000 United States dollar | superseded | [clm_96D7602C8C14](/claim/clm_96D7602C8C14.md)
- 2024-06-30 to 2024-09-30 | quarterly_revenue | 357,016,000 United States dollar | superseded | [clm_C182C14AC7C6](/claim/clm_C182C14AC7C6.md)
- 2024-06-30 to 2024-09-30 | cash_and_equivalents | 252,435,000 United States dollar | superseded | [clm_F7ED2194EA74](/claim/clm_F7ED2194EA74.md)
- 2024-08-02 to 2024-11-01 | shares_outstanding | 66,908,736 shares | superseded | [clm_EB261704CBCE](/claim/clm_EB261704CBCE.md)
- 2024-09-30 to 2024-12-31 | total_assets | 980,208,000 United States dollar | superseded | [clm_2EA849348060](/claim/clm_2EA849348060.md)
- 2024-09-30 to 2025-03-31 | quarterly_revenue | 360,344,000 United States dollar | superseded | [clm_834311EE5278](/claim/clm_834311EE5278.md)
- 2024-09-30 to 2024-12-31 | cash_and_equivalents | 261,588,000 United States dollar | superseded | [clm_8D590D4BC0C2](/claim/clm_8D590D4BC0C2.md)
- 2024-09-30 to 2025-03-31 | quarterly_operating_income | 46,652,000 United States dollar | superseded | [clm_9382D1631DB7](/claim/clm_9382D1631DB7.md)
- 2024-09-30 to 2024-12-31 | total_equity | 739,540,000 United States dollar | superseded | [clm_ADD3217CFF83](/claim/clm_ADD3217CFF83.md)
- 2024-09-30 to 2025-03-31 | quarterly_net_income | 38,440,000 United States dollar | superseded | [clm_DD2E42A6F24F](/claim/clm_DD2E42A6F24F.md)
- 2024-11-01 to 2025-02-18 | shares_outstanding | 65,817,690 shares | superseded | [clm_D2374974DABE](/claim/clm_D2374974DABE.md)
- 2024-12-31 to 2025-03-31 | total_equity | 743,969,000 United States dollar | superseded | [clm_12B4D68A010E](/claim/clm_12B4D68A010E.md)
- 2024-12-31 to 2025-03-31 | total_assets | 983,567,000 United States dollar | superseded | [clm_31B0CF139359](/claim/clm_31B0CF139359.md)
- 2024-12-31 to 2025-12-31 | research_and_development | 310,500,000 United States dollar | superseded | [clm_6D2AC47243CA](/claim/clm_6D2AC47243CA.md)
- 2024-12-31 to 2025-12-31 | revenue | 1,412,064,000 United States dollar | superseded | [clm_729F838E75C1](/claim/clm_729F838E75C1.md)
- 2024-12-31 to 2025-12-31 | net_income | 132,850,000 United States dollar | superseded | [clm_A1F230B01080](/claim/clm_A1F230B01080.md)
- 2024-12-31 to 2025-12-31 | operating_income | 151,045,000 United States dollar | superseded | [clm_A42A8E0A33EE](/claim/clm_A42A8E0A33EE.md)
- 2024-12-31 to 2025-03-31 | cash_and_equivalents | 217,325,000 United States dollar | superseded | [clm_ADCE7A1613C4](/claim/clm_ADCE7A1613C4.md)

## 2025

- 2025-02-18 to 2025-05-02 | shares_outstanding | 65,033,177 shares | superseded | [clm_4B54F19EB363](/claim/clm_4B54F19EB363.md)
- 2025-03-31 to 2025-06-30 | total_equity | 728,018,000 United States dollar | superseded | [clm_0E866C81B1AC](/claim/clm_0E866C81B1AC.md)
- 2025-03-31 to 2025-06-30 | cash_and_equivalents | 222,028,000 United States dollar | superseded | [clm_532360EE98AE](/claim/clm_532360EE98AE.md)
- 2025-03-31 to 2025-06-30 | quarterly_net_income | 24,391,000 United States dollar | superseded | [clm_60CB90AEA602](/claim/clm_60CB90AEA602.md)
- 2025-03-31 to 2025-06-30 | quarterly_revenue | 358,534,000 United States dollar | superseded | [clm_888EAC16462D](/claim/clm_888EAC16462D.md)
- 2025-03-31 to 2025-06-30 | quarterly_operating_income | 29,460,000 United States dollar | superseded | [clm_9EE85A747367](/claim/clm_9EE85A747367.md)
- 2025-03-31 to 2025-06-30 | total_assets | 985,203,000 United States dollar | superseded | [clm_A7D37FB5CB62](/claim/clm_A7D37FB5CB62.md)
- 2025-05-02 to 2025-08-01 | shares_outstanding | 63,842,428 shares | superseded | [clm_4F8375571B92](/claim/clm_4F8375571B92.md)
- 2025-06-30 to 2025-09-30 | cash_and_equivalents | 197,687,000 United States dollar | superseded | [clm_14D4B7426977](/claim/clm_14D4B7426977.md)
- 2025-06-30 to 2025-09-30 | quarterly_net_income | 44,089,000 United States dollar | superseded | [clm_2729585E5A62](/claim/clm_2729585E5A62.md)
- 2025-06-30 to 2025-09-30 | total_assets | 980,175,000 United States dollar | superseded | [clm_819EB87B5E44](/claim/clm_819EB87B5E44.md)
- 2025-06-30 to 2025-09-30 | quarterly_revenue | 370,394,000 United States dollar | superseded | [clm_9E2984FBAD6F](/claim/clm_9E2984FBAD6F.md)
- 2025-06-30 to 2025-09-30 | quarterly_operating_income | 53,290,000 United States dollar | superseded | [clm_AEF7C79DDC17](/claim/clm_AEF7C79DDC17.md)
- 2025-06-30 to 2025-09-30 | total_equity | 746,404,000 United States dollar | superseded | [clm_EB7B8CFD35BE](/claim/clm_EB7B8CFD35BE.md)
- 2025-08-01 to 2025-10-31 | shares_outstanding | 63,060,655 shares | superseded | [clm_352EB19E9600](/claim/clm_352EB19E9600.md)
- 2025-08-19 | board_member | Logan Green | valid | [clm_ED35E66BE644](/claim/clm_ED35E66BE644.md)
- 2025-09-30 to 2025-12-31 | cash_and_equivalents | 231,071,000 United States dollar | superseded | [clm_00E056F947FE](/claim/clm_00E056F947FE.md)
- 2025-09-30 to 2025-12-31 | total_equity | 733,153,000 United States dollar | superseded | [clm_04EA655EA169](/claim/clm_04EA655EA169.md)
- 2025-09-30 to 2026-03-31 | quarterly_revenue | 376,038,000 United States dollar | superseded | [clm_0DE6B8E8896F](/claim/clm_0DE6B8E8896F.md)
- 2025-09-30 to 2025-12-31 | total_assets | 989,884,000 United States dollar | superseded | [clm_31684C863F8A](/claim/clm_31684C863F8A.md)
- 2025-09-30 to 2026-03-31 | quarterly_net_income | 39,324,000 United States dollar | superseded | [clm_B290714DF56C](/claim/clm_B290714DF56C.md)
- 2025-09-30 to 2026-03-31 | quarterly_operating_income | 52,885,000 United States dollar | superseded | [clm_D9B845A18B91](/claim/clm_D9B845A18B91.md)
- 2025-10-31 to 2026-02-17 | shares_outstanding | 61,491,989 shares | superseded | [clm_4369F66FFD03](/claim/clm_4369F66FFD03.md)
- 2025-12-31 | employees | 5,168 | valid | [clm_07B3EDA21306](/claim/clm_07B3EDA21306.md)
- 2025-12-31 to 2026-03-31 | total_assets | 958,478,000 United States dollar | superseded | [clm_2AC95127CD98](/claim/clm_2AC95127CD98.md)
- 2025-12-31 to 2026-03-31 | total_equity | 710,852,000 United States dollar | superseded | [clm_4A6908DBD701](/claim/clm_4A6908DBD701.md)
- 2025-12-31 | research_and_development | 297,800,000 United States dollar | valid | [clm_4FB82CABA62C](/claim/clm_4FB82CABA62C.md)
- 2025-12-31 | revenue | 1,464,955,000 United States dollar | valid | [clm_90705F819D22](/claim/clm_90705F819D22.md)
- 2025-12-31 | operating_income | 184,521,000 United States dollar | valid | [clm_BF5345E5AF6A](/claim/clm_BF5345E5AF6A.md)
- 2025-12-31 to 2026-03-31 | cash_and_equivalents | 216,062,000 United States dollar | superseded | [clm_DAF7AFF29736](/claim/clm_DAF7AFF29736.md)
- 2025-12-31 | net_income | 145,600,000 United States dollar | valid | [clm_E3C63CA8B234](/claim/clm_E3C63CA8B234.md)

## 2026

- 2026-02-17 to 2026-05-01 | shares_outstanding | 59,517,013 shares | superseded | [clm_B0B7DF757EC6](/claim/clm_B0B7DF757EC6.md)
- 2026-03-31 to 2026-06-30 | quarterly_net_income | 17,735,000 United States dollar | superseded | [clm_27E311689C62](/claim/clm_27E311689C62.md)
- 2026-03-31 to 2026-06-30 | quarterly_operating_income | 27,298,000 United States dollar | superseded | [clm_2BF1E897B222](/claim/clm_2BF1E897B222.md)
- 2026-03-31 to 2026-06-30 | total_assets | 1,013,298,000 United States dollar | superseded | [clm_4A7318A55B39](/claim/clm_4A7318A55B39.md)
- 2026-03-31 to 2026-06-30 | quarterly_revenue | 361,457,000 United States dollar | superseded | [clm_80AA1B64B733](/claim/clm_80AA1B64B733.md)
- 2026-03-31 to 2026-06-30 | cash_and_equivalents | 110,412,000 United States dollar | superseded | [clm_87BEFE80D0DD](/claim/clm_87BEFE80D0DD.md)
- 2026-03-31 to 2026-06-30 | total_equity | 631,089,000 United States dollar | superseded | [clm_DBC133E75553](/claim/clm_DBC133E75553.md)
- 2026-05-01 to 2026-07-31 | shares_outstanding | 54,990,704 shares | superseded | [clm_E8F3C8CFA976](/claim/clm_E8F3C8CFA976.md)
- 2026-06-30 | quarterly_net_income | 31,652,000 United States dollar | valid | [clm_099A97B3C7E0](/claim/clm_099A97B3C7E0.md)
- 2026-06-30 | total_equity | 644,527,000 United States dollar | valid | [clm_13D54930B0A9](/claim/clm_13D54930B0A9.md)
- 2026-06-30 | total_assets | 990,565,000 United States dollar | valid | [clm_27B10101084C](/claim/clm_27B10101084C.md)
- 2026-06-30 | quarterly_revenue | 375,519,000 United States dollar | valid | [clm_C1D3A289E8E9](/claim/clm_C1D3A289E8E9.md)
- 2026-06-30 | quarterly_operating_income | 43,730,000 United States dollar | valid | [clm_E99A91FBB387](/claim/clm_E99A91FBB387.md)
- 2026-06-30 | cash_and_equivalents | 94,142,000 United States dollar | valid | [clm_FB2898810CDD](/claim/clm_FB2898810CDD.md)
- 2026-07-31 | shares_outstanding | 54,263,621 shares | valid | [clm_84B9F4754230](/claim/clm_84B9F4754230.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.